Strategy of diagnosis and management of intra-abdominal infection after gastrointestinal surgery
G. Citerio,C. Giussani,Hugo Sax,Didier Pittet,Xiaoyan Wen,John A. Kellum,Angela M. Mills,Nova L. Panebianco,Stuart M. Flechner,Jean Carlet,Andie S. Lee,Stephan Jürgen Harbarth,Jason Ferries,Christian Sandrock,Daniel Scheurich,Hilary M. Babcock,Katherine Mandell,Gregory J. Jurkovich,Clay Cothren Burlew,Ernest E. Moore,Philip F. Stahel,Michael A. Flierl,Christoph E. Heyde,L. D. Britt,Howard R. Champion,Russ Hewson,Rupert M. Pearse,Martin Damm,Marcelo Gama de Abreu,Kevin W. Finkel,Manu L. N. G. Malbrain,Lewis J. Kaplan,J. Claude Hemphill,Jacob Freeman,Andrew M. Bauer,Daniel K. Resnick,Thomas Luecke,Jonathan I. Fischer,Anthony J. Dean,Christiane S. Hartog,Konrad Reinhart,Ryan P. Morrissey,Lewis S. Nelson
2013-01-01
Abstract:Intra-abdominal infection after gastrointestinal operation has become an important cause of morbidity and are frequently associated with poor prognosis. Factors consistently associated with poor outcomes in patients with intra-abdominal infections include increased illness severity, failed source control, inadequate empiric antimicrobial therapy and healthcare-acquired infection. Early prognostic evaluation of complicated intra-abdominal infections is important to select high-risk patients for more aggressive therapeutic procedures. The key point in the management of complicated intra-abdominal infections is both source control and antibiotic therapy. The timing and the adequacy of source control are the most important issues in the management of intra-abdominal infections. Empiric antimicrobial therapy is important in the overall management of intra-abdominal infections. Inappropriate antibiotic therapy may result in poor patient outcomes and in the appearance of bacterial resistance. A deescalation approach may be recommended in patients with specific risk factors for multidrug resistant infections such as immunodeficiency and prolonged antibacterial exposure.